Rybelsus 7 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FGTAK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,865
Award facts
- Contract value 100% obligated
- $12,865.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $12,865.23 by the Defense Logistics Agency (DLA) for the supply of Rybelsus 7 mg tablets in quantities of 30 units. The contract represents a firm fixed price delivery order with no set-aside designation, indicating competitive award to this qualified pharmaceutical distributor. The award was issued on June 24, 2025, with an ultimate completion date of June 25, 2025. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (designated SPE2DX), which carries a potential value of $999,999,999.00 and extends through December 2026.
As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The DLA Medical Supply Chain utilizes this prime vendor relationship to procure medications across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for Rybelsus, a diabetes medication, exemplifies the company's role in fulfilling routine pharmaceutical supply needs for military medical operations on a global scale. The non-competitive nature of this award reflects AmerisourceBergen Drug Corp's pre-established position as a prime vendor under the broader DLA framework.
Quick answers
Who was awarded contract SPE2DB25FGTAK?
SPE2DB25FGTAK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 24, 2025.
How much is contract SPE2DB25FGTAK worth?
The government has obligated $12,865 on SPE2DB25FGTAK.
Is contract SPE2DB25FGTAK an order under another contract?
Yes. SPE2DB25FGTAK is a delivery order under SPE2DB24D2215, an indefinite delivery contract.
Was contract SPE2DB25FGTAK competed?
The extent of competition for SPE2DB25FGTAK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award